Table 2.
Within group and between group changes in anthropometric, laboratory, and quality-of-life outcomes.
| Parameter | IWL N=6 |
p-value[1] | SCN N=5 |
p-value[1] | Group Difference | p-value[2] |
|---|---|---|---|---|---|---|
| Weight (kg) | −14 ± 6 | 0.00 | −5 ± 5 | 0.09 | 10 | 0.02 |
| Change in weight (%) | 13 ± 5 | 0.00 | 4 ± 4 | 0.07 | 9 | 0.01 |
| BMI (kg/m2) | −5 ± 2 | 0.00 | −2 ± 2 | 0.09 | 4 | 0.02 |
| Systolic Blood Pressure (mmHg) | −2 ± 6 | 0.41 | −6 ± 6 | 0.08 | 4 | 0.34 |
| Diastolic Blood Pressure (mmHg) | −5 ± 4 | 0.05 | 0 ± 11 | 1.00 | 5 | 0.39 |
| Lipids | ||||||
| Total Cholesterol (mg/dl) | −7 ± 17 | 0.36 | 9 ± 19 | 0.38 | 15 | 0.19 |
| Triglycerides (mg/dl) | −27 ± 55 | 0.29 | 31 ± 62 | 0.33 | 57 | 0.14 |
| HDL (mg/dl) | −1 ± 6 | 0.71 | 2 ± 5 | 0.34 | 3 | 0.36 |
| LDL (mg/dl) | −4 ± 9 | 0.30 | 1 ± 11 | 0.91 | 5 | 0.44 |
| Fasting glucose (mg/dL) | −9 ± 6 | 0.01 | 1 ± 9 | 0.83 | 10 | 0.05 |
| Insulin (μU/mL) | −10 ± 4 | 0.00 | 4 ± 14 | 0.64 | 14 | 0.05 |
| HOMA-IR | −3 ± 1 | 0.00 | 1 ± 4 | 0.55 | 4 | 0.03 |
| EQ-5D Index | 0.05 ± 0.08 | 0.21 | −0.01 ± 0.07 | 0.84 | 0.06 | 0.26 |
| EQ-5D Health Score | 13 ± 14 | 0.07 | −3 ± 12 | 0.63 | 16 | 0.07 |
| IDS-SR | −5 ± 4 | 0.02 | 2 ± 7 | 0.60 | 7 | 0.07 |
[1]
p-value based on paired t-test
[2]
p-value based on two-sample t-test
Mean ± standard deviation reported
BMI, body mass index; HDL, high-density lipoproteins; LDL, low-density lipoproteins; HOMA-IR, homeostatic model assessment-insulin resistance; EQ-5D, EuroQol-5D; IDS-SR, Inventory of Depressive Symptomatology (Self-Report)